ESET researchers uncovered fraudulent apps on Google Play that claim to provide the call history “for any number” and had ...

In 2026, AI assistants like Gemini, Remy, and ChatGPT are shifting from passive question-answering to actively completing tasks, managing routines, and building applications. With deeper integration ...

Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.

David Pogue is a six-time Emmy winner for his stories on "CBS Sunday Morning," where he's been a correspondent since 2002. Pogue hosts the CBS News podcast "Unsung Science." He's also a New York Times ...

Discover over 30 free Google AI tools designed to enhance your productivity, streamline content creation, and simplify coding ...

Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process. Historically, trials have required tedious tabulations and repeated ...

Homeowners checking on their investment, prospective buyers researching values and curious lookie-loos lost access to the Maryland Department of Assessments and Taxation’s real property database ...

On a Saturday morning, you head to the hardware store. Your neighbors’ Ring cameras film your walk to the car. Your car’s sensors, cameras and microphones record your speed, how you drive, where ...

LakeFusion, a Databricks-native Master Data Management (MDM) platform, has closed a $7.5 million Seed round led by Silverton ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with two major industry players already taking part in a pilot program.

Oracle and BorderPlex Digital Assets will use fuel cells made by Bloom Energy for Oracle's Project Jupiter data-center campus in New Mexico. Bloom will supply the campus with up to 2.45 gigawatts of ...

WHITE OAK, MD – The US Food and Drug Administration (FDA) has announced plans for a future pilot program intended to facilitate the real-time review of clinical trials by regulators, as well as the ...